Implementation Grant Funding Opportunity Open
IMPORTANT: The grant program operates on a rolling basis and applications may be submitted at any time, with quarterly reviews.
Learn More
Implementation Grant Funding Opportunity Open
Qualifying* small and medium-sized US manufacturers, that received IAC or Combined Heat and Power Technical Assistance Partnership assessments between 2018 and 2024, can now apply for grants for implementation of assessment recommendations up 50% of qualifying* project costs with a maximum of $300,000 per manufacturer.
IMPORTANT: The grant program now operates on a rolling basis and applications may be submitted at any time through the year, with quarterly reviews.
*See Full Grant Solicitation for full qualification and selection details.
150
matching assessments| SIC | 2834 | Pharmaceutical Preparations |
|---|
| ID | Year | Products | Reccs | Plant Energy Costs | Recommended Savings |
|---|---|---|---|---|---|
| MI0255 | 2014 |
MI0255 | 2014
Steel Products
|
11 | $143,770 | $50,716 |
| MI0253 | 2013 |
MI0253 | 2013
Pharmacuticals
|
8 | $1,224,528 | $340,867 |
| MI0252 | 2013 |
MI0252 | 2013
Pharmacuticals
|
9 | $567,341 | $76,704 |
| MI0251 | 2013 |
MI0251 | 2013
Pharmacutical
|
13 | $2,258,245 | $226,977 |
| UK1317 | 2013 |
UK1317 | 2013
Oral Solid Dosage Drugs
|
6 | $1,322,510 | $191,185 |
| DL0107 | 2013 |
DL0107 | 2013
Pharmaceuticals
|
7 | $1,904,479 | $314,431 |
| DL0102 | 2013 |
DL0102 | 2013
Custom Pharmaceutical
|
6 | $735,269 | $71,140 |
| SU0338 | 2013 |
SU0338 | 2013
Oral solid dose pharmaceuticals
|
10 | $1,727,704 | $256,101 |
| NC0479 | 2013 |
NC0479 | 2013
Pharmaceuticals
|
9 | $305,800 | $20,938 |
| WV0461 | 2013 |
WV0461 | 2013
clinical testing material
|
9 | $7,061,689 | $327,016 |
| MZ0083 | 2012 |
MZ0083 | 2012
pharmaceutical
|
5 | $113,772 | $29,886 |
| NC0443 | 2012 |
NC0443 | 2012
Pharmaceuticals
|
6 | $1,043,858 | $69,878 |
| UF0449 | 2011 |
UF0449 | 2011
medical devices
|
11 | $110,215 | $18,758 |
| IC0185 | 2011 |
IC0185 | 2011
pharmaceutical excipient
|
7 | $888,505 | $330,199 |
| MA0672 | 2011 |
MA0672 | 2011
Pharmaceutical compounds
|
7 | $759,230 | $155,561 |
| MS0371 | 2011 |
MS0371 | 2011
Milk of Magnesia
|
7 | $270,654 | $28,680 |
| SD0501 | 2010 |
SD0501 | 2010
Biopharmaceuticals
|
4 | $1,670,091 | $81,814 |
| DL0053 | 2010 |
DL0053 | 2010
Pharmaceuticals
|
15 | $5,599,661 | $1,057,600 |
| WV0397 | 2009 |
WV0397 | 2009
Pharmaceutical Pills
|
11 | $3,462,203 | $493,360 |
| SF0378 | 2009 |
SF0378 | 2009
Dermalogical pharmaceuticals
|
8 | $602,057 | $53,407 |
| UD0803 | 2009 |
UD0803 | 2009
Pharmaceuticals
|
16 | $1,248,877 | $501,437 |
| LE0289 | 2009 |
LE0289 | 2009
pharmaceutical
|
10 | $172,405 | $75,809 |
| UM0350 | 2009 |
UM0350 | 2009
Excipients of Medical Capsules
|
8 | $351,163 | $51,548 |
| DL0028 | 2008 |
DL0028 | 2008
Pharmaceutical Preparations
|
10 | $1,943,700 | $355,670 |
| MS0335 | 2008 |
MS0335 | 2008
Pharmaceuticals
|
8 | $2,474,127 | $140,143 |